Literature DB >> 7338618

Eosinophilic gastroenteritis and ascites.

W A Harmon, C A Helman.   

Abstract

A 53-year-old white man complained of massive abdominal swelling of 10 days duration. He gave a 20-year-old history of atopy, epigastric burning, and cramping abdominal pain. Peripheral eosinophilia (4420/mm3), exudative ascites, with 99% eosinophils; compatible endoscopic and contrast x-ray findings; and typical findings on small bowel peroral biopsy made the diagnosis of eosinophilic gastroenteritis with ascites. The clinical features and laboratory findings of our case are compared to the 14 cases found in reviewing the English literature. Therapy with corticosteroids resulted in resolution of both the gastrointestinal symptoms and the ascites within a 4-week period.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7338618     DOI: 10.1097/00004836-198112000-00013

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

Review 1.  Eosinophilic gastroenteritis with ascites: a case report and review of the literature.

Authors:  L M Fenoglio; V Benedetti; C Rossi; A Anania; K Wulhfard; M Trapani; E Scalabrino; G Alberto; D Novero; P Cavalloperin
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

2.  Toxocara canis infection presenting as eosinophilic ascites and gastroenteritis.

Authors:  J L Van Laethem; F Jacobs; P Braude; A Van Gossum; J Deviere
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

3.  Acute eosinophilic ascites in a middle-aged man.

Authors:  Fadi Bleibel; Keith Fragoza; Garrey T Faller
Journal:  Case Rep Gastrointest Med       Date:  2012-05-08

4.  Hypereosinophilic syndrome presenting as eosinophilic gastroenteritis disorder and splinter hemorrhages: A case report.

Authors:  Ankith Bhasi; Itish Patnaik; Prasan Kumar Panda; Ashok Singh
Journal:  World J Gastrointest Pharmacol Ther       Date:  2022-03-05

Review 5.  Serous fluids and hematolymphoid disorders.

Authors:  Ali Gabali
Journal:  Cytojournal       Date:  2022-03-19       Impact factor: 2.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.